Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhuanggu Shenjin Capsules is a traditional Chinese medicine (TCM) herbal formulation developed and marketed by Zhejiang H.Power Pharmaceutical. It is primarily indicated for the treatment of musculoskeletal conditions, including bone and muscle pain, stiffness, and support, according to traditional Chinese medicine principles. The formulation typically includes a complex mixture of herbal ingredients such as red ginseng (*Panax ginseng*), dog bone, Indian bread (*Poria cocos*), yanhusuo (*Corydalis yanhusuo*), and datura flower. Key active constituents identified in research on this formulation include ginsenosides, tetrahydropalmatine, and icariin. As a TCM product, it functions through the synergistic effects of its multiple herbal components rather than a single defined molecular target. It is approved for use in China and administered orally in capsule form.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhuanggu Shenjin Capsules.